Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in Japan

The Pharmaceuticals and Medical Devices Agency (PMDA) has conducted many pharmacoepidemiological studies for postmarketing drug safety assessments based on real-world data from medical information databases. One of these databases is the National Database of Health Insurance Claims and Specific Heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Shida, Haruka, Kajiyama, Kazuhiro, Sawada, Sono, Ishiguro, Chieko, Kubo, Mikiko, Kimura, Ryota, Hirano, Mai, Komiyama, Noriyuki, Iguchi, Toyotaka, Oniyama, Yukio, Uyama, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995365/
https://www.ncbi.nlm.nih.gov/pubmed/36910503
http://dx.doi.org/10.3389/fmed.2023.1096992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995365/
https://www.ncbi.nlm.nih.gov/pubmed/36910503
http://dx.doi.org/10.3389/fmed.2023.1096992

Ejemplares similares